Boston Therapeutics Inc (OTCQB:BTHE)

Data as of Jan 30
 -0.0699 / -15.89%
Today’s Change
Today|||52-Week Range
Health Technology
Pharmaceuticals: Other

Company Description

Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products include therapeutic modules such as BTI320, Ipoxyn, and Oxyfex. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Manchester, NH.

Contact Information

Boston Therapeutics, Inc.
1750 Elm Street
Manchester New Hampshire 03104
P:(603) 935-9799
Investor Relations:



Individual stakeholders42.39%
Mutual fund holders--
Other institutional--

Top Executives

David PlattChairman, Chief Executive Officer & Treasurer
Louise GelinasDirector-Business Operations
Anthony Don SquegliaChief Financial & Accounting Officer
Benjamin RivnayChief Scientist
Eric HobermanManager-Clinical Affairs

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.